Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy—Preliminary Results From a Prospective Single-Center Study

Overview of attention for article published in Frontiers in endocrinology, May 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 1 X user

f1000: 1 research highlight platform

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Research highlights Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,821 followers.

New Research: Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy—Preliminary Results From a Prospective Single-Center Study: Objective Management of Graves’ orbitopathy remains a challenge. Our previous case report… https://t.co/azp0Xbigc

09 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.